To explain the potential reasons for the sensitization to ICI therapy with cuproptosis treatment, we analyzed tumor tissues by serial sections and evaluated the infiltration of CD4+ and CD8+ T cells among different treatment groups using immunohistochemistry. The gene discussed is CD4; the disease is neoplasm.